Kinasuhan sin sina Family Health Office officer-in-charge Joyce Ducusin; Philippine Children’s Medical Center Director Julius Lecciones; Family Health Office Medical Specialist II Dr. Maria Wilda Silva; DOH- Disease Prevention and Control Bureau Director IV Mario Baquilod; at Dr. Rosalind Vianzon.
“There is technical malversation because government funds amounting to P3 billion intended for the 2015 Miscellaneous Personnel Benefit Fund (MPBF) of the Executive Department was utilized for the procurement of Dengvaxia under the DOH school-based immunization program. Although the source of fund was declared as savings by the Chief Executive, its intended purpose failed as there is no existing rpograms, activity or project for dengue procurement and immunization,” sabi ng NBI sa sulat kay Ombudsman Conchita Carpio-Morales na may petsang Hulyo 13, 2018.
Hiniling ng NBI sa Ombudsman na magsagawa ng preliminary investigation kaugnay sa isyu.
Inirekomenda rin ng NBI ang pagsasampa ng kasong technical malversation laban kay dating Health secretary Paulyn Ubial matapos namang ituloy ang proyekto
Umabot sa P3.5 bilyon Dengvaxia ang binili para sa mabakunahan ang 830,000 bata.
“Parents of vaccinated children, regardless of status, was shaken by the latest discovery of Sanofi Pasteur, Inc. (SPI) that the Dengvaxia should not be introduced to seronegative individuals,” sabi ni NBI Director Dante Gierran.